Breast Cancer Risk Rapidly Declined After Women Stopped Taking Postmenopausal Combine
 

Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator. The study, based on data from the Women's Health Initiative, will be published Wednesday in The New England Journal of Medicine.

More...